Skip to main content

Advertisement

SpringerLink
Log in

Kidney function after the intraoperative use of 6 % tetrastarches (HES 130/0.4 and 0.42)

  • Invited Review Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Concerns about the nephrotoxicity of tetrastarches have recently increased with the accumulation of new evidence, particularly in relationship to septic patients. Two meta-analyses in 2011 and early 2012 also raised concerns about nephrotoxicity in surgical patients and prompted the present review of the nephrotoxicity of tetrastarches solely in the surgical setting. Seven reports consisting of two review articles and five single-trial papers published between 2012 and August 2013 were examined. Six of the seven studies did not show any adverse renal outcomes following the intraoperative use of tetrastarch, although their data are not robust enough to confirm definitive safety. Moreover, balanced electrolyte solutions are strongly recommended as a carrier solution for tetrastarches to reduce adverse outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bayer O, Reinhart K, Kohl M, Kabisch B, Marshall J, Sakr Y, Bauer M, Hartog C, Schwarzkopf D, Riedemann N. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med 2012;40:2543–51.

    Google Scholar 

  2. Hasse N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839.

    Article  Google Scholar 

  3. Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function (review). Cochrane Database Syst Rev 2013;7:CD007594.

  4. Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med. 2013;39:811–22.

    Article  PubMed  CAS  Google Scholar 

  5. Zarychanski B, Abou-Setta AM, Tugeon AF, Houston BL, McIntyre L, Marshall JC. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation. JAMA. 2013;309:678–88.

    Article  PubMed  CAS  Google Scholar 

  6. Wiedermann CJ, Joannidis M. Mortality after hydroxyethyl starch 130/0.4 infusion: an updated meta-analysis of randomized trials. Swiss Med Wkly. 2012;142:w13656.

    PubMed  Google Scholar 

  7. Gattas DJ, Dan A, Mybururgh J, Billot L, Lo S, Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systemic review and meta-analysis. Anesth Analg. 2012;114:159–69.

    Article  PubMed  Google Scholar 

  8. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg. 2011;112:635–45.

    Article  PubMed  CAS  Google Scholar 

  9. Calvert S, Shaw A. Perioperative acute kidney injury. Perioper Med. 2012;1:6.

    Article  Google Scholar 

  10. Parida S, Badhe AS. Cardiac surgery-associated acute kidney injury. J Anesth. 2013;27:433–46.

    Article  PubMed  Google Scholar 

  11. Hogan JJ. The intravenous use of colloidal (gelatin) solutions in shock. JAMA. 1915;64:721–6.

    Article  CAS  Google Scholar 

  12. Westphal M, James MFM, Kozeki-Langenecker S, Stocker R, Guidet B, Aken HV. Hydroxyethyl starches. Anesthesiology. 2009;111:187–202.

    Article  PubMed  CAS  Google Scholar 

  13. Legendre C, Thervet E, Page B, Percheron A, Noël L, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:238–9.

    Article  Google Scholar 

  14. Simon TP, Schuerholz T, Hüter L, Sasse M, Heyder F, Pfister W, Marx G. Impairment of renal function using hyperoncotic colloids in a two hit model of shock: a prospective randomized study. Crit Care. 2012;16:R16.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Der Linden Van, James M, Mythen M, Weiskoph RB. Safety of modern starches used during surgery. Anesth Analg. 2013;116:35–48.

    Article  CAS  Google Scholar 

  16. Boussekey N, Damon R, Langlois J, Alfandari S, Devos P, Meybeck A, Chiche A, Grorges H, Leroy O. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care. 2010;14:R40.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Hüter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care. 2009;13:R23.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Neuhaus W, Schick MA, Bruno RR, Schneiker B, Förster CY, Roewer N, Wunder C. The effects of colloid solutions on renal proximal tubular cells in vitro. Anesth Analg. 2012;114:371–4.

    Article  PubMed  CAS  Google Scholar 

  19. Silva PL, Güldner A, Uhlig C, Carvalho N, Beda A, Rentzsch I, Kasper M, Wiedemann B, Spieth PM, Koch T, Capelozi VL, Pelosi P, Rocco PRM, Gama de Abreu M. Effects of intravascular volume replacement on lung and kidney function and damage in nonseptic experimental lung injury. Anesthesiology. 2013;1138:395–408.

    Article  Google Scholar 

  20. Ertmer C, Kampmeier TG, Rehberg S, Morelli A, Köhler G, Lange M, Bollen Pinto B, Höhn C, Hahnenkamp K, Van Aken H, Westphal M. Effects of balanced crystalloid vs. 0.9% saline-based vs. balanced 6% tetrastarch infusion on renal function and tubular integrity in ovine endotoxemic shock. Crit Care Med. 2011;39:783–92.

    Article  PubMed  CAS  Google Scholar 

  21. Perner A, Hasse N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AI, Fabritius MI, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367:124–34.

    Google Scholar 

  22. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArther C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012; 367:1901–11.

  23. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure- definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–12.

    Google Scholar 

  24. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R, The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228.

    Google Scholar 

  25. Martin C, Jacob M, Vicaut E, Guidet B, Aken HV, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387–94.

    Article  PubMed  CAS  Google Scholar 

  26. Feldheiser A, Pavlova V, Bonomo T, Jones A, Fotopoulou C, Sehouli J, Wemecke KD, Spies C. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth. 2013;110:231–40.

    Article  PubMed  CAS  Google Scholar 

  27. Gurbutz HA, Durukan AB, Salman N, Tavlasoglu M, Durukan E, Ucar HI, Yorgancioglu C. Hydroxyethyl starch 6 %, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. J Cardiothorac Surg. 2013;8:71. doi:10.1186/1749-8090-8-71.

    Google Scholar 

  28. Van Der Linden P, De Villé A, Hofer A, Heschl M, Gombotz H. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology 2013 (Epub ahead of print).

  29. Akkucuk FG, Kanbak M, Ayhan B, Celebioglu B, Aypar U. The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery. Ren Fail. 2013;35:210–5.

    Article  PubMed  CAS  Google Scholar 

  30. Ishikawa S, Griesdale DEG, Lohser J. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg. 2012;114:1256–62.

    Article  PubMed  Google Scholar 

  31. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Bayer O, Schwarzkopf D, Doenst T, Cook D, Kabisch B, Schelenz C, Bauer M, Riedemann N, Sakr Y, Kohl M, Reinhart K, Hartog C. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery: a prospective sequential analysis. Crit Care Med 2013; doi:10.1097/CCM.0b013e3182978fb6.

  33. Wijeysundera DN, Karkouti K, Dupuis JY, Rao V, Chan CT, Granton JT, Beattie WS. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA. 2007;25:1801–9.

    Article  Google Scholar 

  34. Gheorghe C, Dadu R, Blot C, Barrantes F, Vazquez R, Berianu F, Feng Y, Feintzig I, Amoateng-Adjepong Y, Manthous CA. Hyperchloremic metabolic acidosis following resuscitation of shock. Chest. 2010;138:1521–2.

    Article  PubMed  Google Scholar 

  35. Sümpelmann R, Kretz F-J, Luntzer R, de Leeuw TG, Mixa V, Gäbler R, Eich C, Hollmann MW, Osthaus WA. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS). Pediatr Anesth. 2012;22:371–8.

  36. Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107–15.

    Article  PubMed  Google Scholar 

  37. Reid F, Lobo DN, Williams RN, Rowlands BJ, Allison SP. (Ab)normal saline and physiological Hartman’ solution: a randomized double-blind crossover study. Clin Sci (Lond). 2003;104:17–24.

    Article  CAS  Google Scholar 

  38. Peng Z-Y, Kellum JA. Perioperative fluids: a clear road ahead? Curr Opin Crit Care. 2013;19:353–8.

    Article  PubMed  Google Scholar 

  39. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs. chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566–72.

    Article  PubMed  CAS  Google Scholar 

  40. Marik PE, Cavallazzi R. Does the central pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013;41:1774–81.

    Article  PubMed  Google Scholar 

  41. Ertmer C, Kampmeier T, Van Aken H. Fluid therapy in critical illness: a special focus on indication, the use of hydroxyethyl starch and its different raw materials. Curr Opin Anesthesiol. 2013;26:253–60.

    CAS  Google Scholar 

  42. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL; Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422–7.

    Google Scholar 

  43. Phillips DP, Kaynar AM, Kellum JA, Gomez H. Crystallids vs. colloids: KO at the twelfth round? Crit Care. 2013;17:319.

    Article  PubMed  Google Scholar 

  44. Bagchi A, Eikermann M. Mashed potatoes and maize: are the starches safe? Anesthesiology. 2013;118:244–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Kuroishi-Kosei Hospital, 9-1 Tateishi, Kuroishi, Aomori, 036-0351, Japan

    Hironori Ishihara

Authors
  1. Hironori Ishihara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hironori Ishihara.

About this article

Cite this article

Ishihara, H. Kidney function after the intraoperative use of 6 % tetrastarches (HES 130/0.4 and 0.42). J Anesth 28, 249–256 (2014). https://doi.org/10.1007/s00540-013-1719-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-013-1719-0

Keywords

Search

Navigation